Literature DB >> 19048418

Matrilysin: a rapidly expanding role in the etiopathogenesis of systemic malignancies.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19048418     DOI： 10.1007/s12032-008-9140-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  5 in total

1.  [Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer].

Authors:  Hong-zhi Luo; Xiu-qiong Xia; Zong-guang Zhou; Lie Yang; Bin Zhou; Chao Tian
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2007-07

2.  Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.

Authors:  Hui Liu; Jing Huang; Benquan Wu; Yuqi Zhou; Jiaxin Zhu; Tiantuo Zhang
Journal:  Med Oncol       Date:  2008-03-14       Impact factor: 3.064

3.  Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.

Authors:  K Kawasaki; T Kawakami; H Watabe; F Itoh; M Mizoguchi; Y Soma
Journal:  Br J Dermatol       Date:  2007-04       Impact factor: 9.302

4.  Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.

Authors:  E Patraki; M R Cardillo
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Oct-Dec       Impact factor: 3.219

5.  Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.

Authors:  Keita Itatsu; Yoh Zen; Junpei Yamaguchi; Shusaku Ohira; Akira Ishikawa; Hiroko Ikeda; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Masatoshi Sasaki; Hiroya Sakamoto; Masato Nagino; Yuji Nimura; Tetsuo Ohta; Yasuni Nakanuma
Journal:  Hum Pathol       Date:  2008-03-10       Impact factor: 3.466
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.